Connect with us

News

Three maternity health innovators shortlisted for award

Published

on

Three maternity health companies have been shortlisted for a Femtech World award.

The event celebrates some of the best examples of leadership, innovation and impact in key areas that affect women’s health and wellbeing.

The Maternity Health Innovation of the Year award honours groundbreaking innovations that have significantly advanced the field of maternity care.

The award is sponsored by TeleScan.

Too many patients will never see a bedside sonographer during their pregnancy, so TeleScan increases access through its telesonography solution.

The software connects providers and their patients with remote perinatal sonographers.

By offering high-quality diagnostics, TeleScan can identify high-risk pregnancies, intervene early, and improve maternal outcomes. 

A winner from the shortlist will be chosen by the sponsor and announced at a virtual ceremony on May 28.

Congratulations to the shortlisted organisations and thank you to everyone who entered.

Maternity Health Innovation Shortlist

Winner of Danish design award 2024, the caramma support bottle is the first air-free bottle designed to allow everyone to feed their child with a slow flow in all natural feeding positions – with or without milk in the breasts.

It is a revolutionary and double patented innovation that fosters heart connection and stimulates oxytocin in parents and babies.

Designed to mimic the natural process, this bottle makes feeding time more meaningful for everyone, avoiding the health risks of other baby bottles.

Curio Digital Therapeutics has pioneered the development of the first and only FDA-approved prescription digital therapeutic (PDT) for treating postpartum depression (PPD) symptoms.

PDTs represent a groundbreaking, scalable solution that addresses persistent barriers to care, including geographic access challenges, high treatment costs, and stigma.

With fewer than 20 FDA-approved PDTs currently on the market, Curio’s MamaLift Plus stands out as the only one specifically designed for women’s health.

Mirvie is the 1st to predict pregnancy complications before they happen by using RNA messages to reveal underlying biology of pregnancy health.

Using a simple blood test, the platform reveals vital information about a pregnancy’s unique biology that drives changes throughout pregnancy.

The result? The power to transform how we predict, prevent and treat unexpected complications.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Scientists turn human skin cells into eggs in IVF breakthrough

Published

on

Researchers have created human eggs from skin cells, in a breakthrough that could transform IVF treatment for couples who have no other options.

The work remains at an early stage, but if scientists can refine the process it could allow women who are infertile due to age, illness or medical treatment to have genetically related eggs.

The same technique could also be used to make eggs for same-sex male couples.

Prof Shoukhrat Mitalipov, who led the research at Oregon Health and Science University in Portland, said: “The largest group of patients who might benefit would be women of advanced maternal age.

“Another group are those who have been through chemotherapy because that can affect their ability to have viable eggs.”

While women are expected to be the primary beneficiaries, the skin cells used to make eggs need not come from potential mothers.

“We used female skin cells in this study, but you could use skin cells from males as well,” Mitalipov told the Guardian.

“You could make eggs for men, and that way, of course, this would be applicable to same-sex couples.”

The work draws on cloning techniques pioneered in the 1990s at the Roslin Institute in Scotland.

A team led by the late Ian Wilmut used somatic cell nuclear transfer – a process that moves genetic material between cells – to create Dolly the sheep.

The procedure involved removing the nucleus (the cell’s control centre containing genetic information) from an adult sheep cell and placing it into a sheep egg that had had its own nucleus removed.

The resulting embryo was carried to term in a surrogate mother.

The Oregon team took a similar approach by collecting skin cells from women and removing the nucleus from each.

The nucleus, which contains 46 chromosomes carrying around 20,000 genes that make up the human genetic code, was placed into healthy donor eggs that had had their own nuclei removed.

The main challenge for scientists was that healthy human eggs normally contain only 23 chromosomes.

Another 23 come from sperm during fertilisation, producing the full set of 46 required for development into an embryo and eventually a baby.

Writing in Nature Communications, the Oregon team described how they tackled the problem of excess chromosomes.

After fertilising the eggs with sperm, they activated them using a compound called roscovitine.

This caused the eggs to move roughly half of their chromosomes into a structure called a polar body – a small cell formed during egg development – leaving the remaining chromosomes to pair with those from the sperm.

In a healthy fertilised human egg, 23 chromosomes from the mother pair with 23 from the father.

However, the Oregon team found that in their lab-created eggs, the chromosomes paired up at random. This led to embryos with the wrong number of chromosomes or incorrect pairings.

“These abnormal chromosome complements would not be expected to result in a healthy baby,” said Prof Paula Amato, a co-author of the study at Oregon.

The team is now working to refine the process.

Of the 82 eggs created, fewer than 10 per cent developed to the stage at which embryos are typically transferred during IVF.

None were cultured beyond six days, suggesting the process remains inefficient.

Mitalipov described the work as a “proof of concept” with more challenges ahead. Perfecting the method and proving its safety in patients could take another decade.

“I think it’s going to be harder than what we’ve done over the years thus far, but it’s not impossible,” he said.

Other scientists praised the breakthrough.

Prof Richard Anderson of the University of Edinburgh said: “Many women are unable to have a family because they have lost their eggs, which can occur for a range of reasons including after cancer treatment.

“The ability to generate new eggs would be a major advance.

“There will be very important safety concerns, but this study is a step toward helping many women have their own genetic children.”

Continue Reading

News

Mothers’, not fathers’, mental health directly linked to their children’s, study shows

Published

on

Mothers’ feelings of being overwhelmed and unhappiness, not fathers’, are directly associated with their children’s feelings of nervousness, worry and unhappiness, new research has revealed.

The study definitively confirms the mother’s role as central to the emotional wellbeing of the family unit.

Though other researchers have focused on isolated relationships between mother and child, this is the first study of the role that both partners may play in family mental health, both concurrently and over time.

Lead author Dr Yushi Bai from The University of Manchester said: “We do know that children’s mental health is formed by, and within, their family through shared genes, nurturing behaviours of caregivers, and sibling dynamics.

“Our study identified mothers, not fathers, as central to the emotional wellbeing of the family unit.

“We suspect that this can be explained by traditional division of parenting roles, where societal expectations often position mothers as the primary caregivers and organisers within families.

“Mothers are typically more involved in child-rearing and spend considerably more time with their children than do fathers, which means they are more likely to influence children’s lives and development.

“Greater exposure to maternal care might also lead children to copy their mother’s coping mechanisms and behaviours.”

The researchers produced a series of maps – called networks – depicting the way symptoms of anxiety and depression in parents and their children up the age of 16 connect with each other over time.

They based the analysis on data from 3,757 families from the UK Household Longitudinal Study between 2009 to 2022.

Additional cross-sectional network maps of 8,795 families captured independent associations between family members’ mental health.

While fathers’ emotional state was linked to mothers’ mental health in the cross-sectional analysis, they observed an absence of associations with their children.

However, they reported that fathers’ emotional symptoms may influence children’s well-being indirectly, by affecting maternal mental health.

The longitudinal maps also identified how a mother’s feelings of being overwhelmed affected the child’s emotional state—especially worry, and that children’s feeling of worry cycled back, further affecting her own emotional health.

The influence of maternal emotional health on their children waned as they got older, reflecting how adolescents transfer their primary attachment from their parents to others.

Co-author Dr Matthias Pierce from The University of Manchester said: “Emotional disorders in young people are not only increasingly prevalent, but also present at early ages, highlighting the need for early intervention and prevention.

“Given the family’s central role in shaping and sustaining mental health, interventions and policies should consider how the family mental health ecosystem operates.

“This study shows the potential value of interventions that aim to support mothers and reduce maternal anxiety, which may have the greatest impact on improving family dynamics and reduce the risk of poor mental health in children.

“We also suggest that the link between fathers’ and mothers’ mental health presents a further potential avenue for alleviating maternal stress.”

Continue Reading

News

Daily pill could delay menopause ‘by years,’ study finds

Published

on

Women who regularly take fish oil supplements could reduce their risk of early menopause by up to 95 per cent, new research suggests.

The study, which looked at data from more than 3,500 British women, found that those who took fish oil supplements were far less likely to experience early menopause than those who did not.

Researchers from the University of Leeds found that regular fish oil use was linked with a 95 per cent lower likelihood of menopause starting earlier than average.

UK nutritional scientist and adviser to Wiley’s Finest supplements Toral Shah, who was not involved in the study, said: “This research adds to a growing body of evidence showing that what we eat and the supplements we take can influence our long-term health in profound ways.

“Omega-3 fatty acids are essential nutrients that our bodies can’t produce on their own, so we must get them through diet or supplementation.”

Menopause usually occurs between ages 45 and 55, though non-white women often reach it sooner. South Asian women, for example, tend to go through menopause around five years earlier.

When menopause happens prematurely – before age 45 – women face increased risks of heart disease, osteoporosis (a condition that weakens bones) and diabetes. When it occurs later – after 55 – the risk of certain hormone-related cancers rises.

The timing of menopause can influence up to one-third of a woman’s life, making it a key public health concern. Researchers analysed data from women in the UK Women’s Cohort Study, tracking their supplement use and lifestyle factors such as diet, exercise and smoking.

Other supplements were also linked with later menopause. Vitamin B-complex was associated with a 52 per cent lower risk, antioxidant combinations (vitamins A, C, E, selenium and zinc) with a 46 per cent reduction, and vitamin C alone with a 25 per cent reduction.

Women who smoked, ate more red meat or had lower educational attainment were more likely to reach menopause earlier.

Researchers believe fish oil may act through several biological pathways.

Omega-3 fatty acids help reduce inflammation and protect the ovaries from oxidative stress – cellular damage that accelerates ageing – while also supporting DNA repair, which is vital for reproductive health.

Shah said: “While fish oil supplements offer a convenient way to ensure adequate omega-3 intake, especially for women who don’t regularly eat oily fish, it’s important to remember that supplements work best as part of a balanced diet and healthy lifestyle.

“The quality of fish oil matters too – look for supplements that are high-quality and provide high levels of EPA and DHA, the active omega-3s, in a form your body can easily absorb.”

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.